Comparison of Berberine and Metformin for the Treatment for MS in Schizophrenia Patients

Clinical trial NCT03708549 · UNKNOWN

Trial details

NCT number: NCT03708549
Sponsor: Tianjin Anding Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Metabolic Syndrome Berberine Metformin

Start date: 2021-12-01
Primary completion: 2023-10-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.